688739 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Liaoning Chengda Biotechnology Co., Ltd. engages in the research, development, manufacture and sale of vaccines. It offers SPEEDA, a rabies vaccine and JEVAC, an inactivated Japanese encephalitis vaccine. The company was founded on June 17, 2002 and is headquartered in Shenyang, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688739 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company